Pulmonary hypertension in POEMS syndrome

Haematologica

Volumn 98, Issue 3, 2013, Pages 393-398

  Li, Jian ^a   Tian, Zhuang ^a   Zheng, Hao Yi ^b   Zhang, Wei ^a   Duan, Ming Hui ^a   Liu, Yong Tai ^a   Cao, Xin Xin ^a   Zhou, Dao Bin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; DEXAMETHASONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN LAMBDA CHAIN; M PROTEIN; MELPHALAN; PREDNISONE; THALIDOMIDE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; ASCITES; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAUSE OF DEATH; COMPARATIVE STUDY; DISEASE ASSOCIATION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PERIPHERAL EDEMA; PLEURA EFFUSION; POEMS SYNDROME; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; BLOOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POEMS SYNDROME; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874540384     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.073031     Document Type: Article

References (29)

1. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011;86(7): 591-601.
2. Dispenzieri A. POEMS Syndrome. Blood Rev. 2007;21(6):285-99.
3. Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011;90(7):819-26.
4. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestations in patients with POEMS syndrome: A retrospective review of 137 patients. Chest. 2008;133(4):969-74.
5. Lesprit P, Godeau B, Authier FJ, Soubrier M, Zuber M, Larroche C, et al. Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines. Am J Respiratory Crit Care Med. 1998;157(3 Pt 1):907-11.
6. Paciocco G, Bossone E, Erba H, Rubenfire M. Reversible pulmonary hypertension in POEMS syndrome: another etiology of triggered pulmonary vasculopathy? Can J Cardiol. 2000;16(8):1007-12.
7. Okura H, Gohma I, Hatta K, Imanaka T. Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome. Intern Med. 1995;34(7):674-5.
8. Jouve P, Humbert M, Chauveheid MP, Jais X, Papo T. POEMS syndrome-related pulmonary hypertension is steroid responsive. Respir Med. 2007;101(2):353-5.
9. Ribadeau-Dumas S, Tillie-Leblond I, Rose C, Saulnier F, Wemeau JL, Hatron PY et al. Pulmonary hypertension associated with POEMS syndrome. Eur Respir J. 1996; 9(8):1760-2
10. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and longterm outcome. Blood. 2003;101(17):2496-506.
11. Hashiguchi T, Arimura K, Matsumuro K, Otsuka R, Watanabe O, Jonosono M, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve. 2000;23(7):1051-6.
12. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI /SCCM/SCCT/SCMR 2011 Appropriate use criteria for echocardiography. J Am Soc Echocardiogr. 2011;24(3):229-67.
13. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984; 70(4):657-62.
14. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. The guidelines for diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34(6):1219-63.
15. Amecian Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202-8.
16. Niimi H, Arimura K, Jonosono M, Hashiguchi T, Kawabata M, Osame M, et al. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Intern Med. 2000; 39(12):1101-4.
17. Helmersen DS, Ford GT, Viner SM, Auger WR. POEMS syndrome: a clue to understanding primary pulmonary hypertension? A review of current insights into the pathogenesis of primary pulmonary hypertension. Can J Cardiol. 2000;16(8):975-81.
18. Feinberg L, Temple D, de Marchena E, Patarca R, Mitrani A. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review. Crit Rev Oncog. 1999;10(4):293-302.
19. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet. 1996;347 (9002):702.
20. Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21(11):1390-7.
21. Soubrier M, Sauron C, Souweine B, Larroche C, Wechsler B, Guillevin L, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999; 34(4):633-8.
22. Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: Role of angiogenic factors in the pathogenesis. Brain. 2005;128(Pt8):1911-20.
23. Kanai K, Kuwabara S, Misawa S, Hattori T. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Intern Med. 2007;46(6):311-3.
24. Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C, et al. Treatment of POEMS syndrome with bevacizumab. Haematologica 2007;92(10): 1438-9.
25. Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood. 2011;117(24):6445-9.
26. D'Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S, et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood. 2012;120(1):56-62.
27. Rached S, Athanazio RA, Dias SA Jr, Jardim C, Souza R. Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome. J Bras Pneumol. 2009;35(8):804-8.
28. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-9.
29. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615-21.